Vertex Stock: Plunges Amid Pain Therapy Setbacks
Despite posting strong Q2 earnings, Vertex Pharmaceuticals faced a 9% stock drop as clinical setbacks in its pain therapy pipeline ...
Despite posting strong Q2 earnings, Vertex Pharmaceuticals faced a 9% stock drop as clinical setbacks in its pain therapy pipeline ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.